C.M. Margulies, et al. Developing a CRISPR/Cas9 Editing Approach for the Treatment of USH2A Related Inherited Retinal Degeneration. Presented at the European Society for Gene and Cell Therapy 27th Annual Congress (ESGCT), October 22-25, 2019.

Apr

22

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

Feb

28

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

Feb

21

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events